| |
| |
|
| Insider
Information: |
Primiano Christopher Brett |
| Relationship: |
Chief Business Officer |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13,273 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,885 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,273 |
|
|
| Total
Value |
$4,885 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
EVP, CBO, GC & Secretary |
2020-12-01 |
4,523 |
2014-05-13 |
0 |
Premium* |
|
|
Aura Biosciences, Inc. |
AURA |
Chief Business Officer |
2021-10-28 |
8,750 |
2021-10-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AURA |
Aura Biosciences, Inc. |
Chief Business Officer |
• – – |
2021-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-12-01 |
4 |
AS |
$17.35 |
$2,402,227 |
D/D |
(137,061) |
4,523 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-12-01 |
4 |
OE |
$10.39 |
$1,428,751 |
D/D |
137,061 |
63,460 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-11-02 |
4 |
AS |
$14.92 |
$11,518 |
D/D |
(772) |
4,523 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-10-13 |
4 |
AS |
$16.85 |
$661,969 |
D/D |
(39,271) |
4,649 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-10-13 |
4 |
OE |
$9.21 |
$362,537 |
D/D |
39,271 |
5,370 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-09-08 |
4 |
AS |
$14.98 |
$150,609 |
D/D |
(10,054) |
4,649 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-09-08 |
4 |
OE |
$6.54 |
$65,753 |
D/D |
10,054 |
14,703 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-05-07 |
4 |
OE |
$6.54 |
$19,267 |
D/D |
2,946 |
7,595 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-05-07 |
4 |
AS |
$19.62 |
$190,627 |
D/D |
(9,660) |
4,649 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-03-02 |
4 |
AS |
$23.50 |
$672,279 |
D/D |
(26,500) |
10,367 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-03-02 |
4 |
OE |
$10.39 |
$275,335 |
D/D |
26,500 |
36,867 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-02-19 |
4 |
S |
$16.48 |
$48,803 |
D/D |
(2,961) |
10,367 |
0 |
% |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,675 |
13,328 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-27 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
3,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-27 |
4 |
OE |
$10.39 |
$51,950 |
D/D |
5,000 |
8,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-06 |
4 |
AS |
$17.45 |
$226,908 |
D/D |
(13,000) |
3,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-06 |
4 |
OE |
$6.54 |
$84,650 |
D/D |
10,000 |
16,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-09-10 |
4 |
AS |
$18.90 |
$189,046 |
D/D |
(10,000) |
2,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-09-10 |
4 |
OE |
$6.54 |
$84,650 |
D/D |
10,000 |
12,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-05-10 |
4 |
AS |
$18.01 |
$36,024 |
D/D |
(2,000) |
2,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-03-05 |
4 |
AS |
$16.03 |
$40,076 |
D/D |
(2,500) |
4,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-02-16 |
4 |
AS |
$15.01 |
$22,298 |
D/D |
(1,486) |
7,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-02-15 |
4 |
AS |
$15.02 |
$15,229 |
D/D |
(1,014) |
8,867 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-02-07 |
4 |
AS |
$13.00 |
$19,500 |
D/D |
(1,500) |
9,881 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
